Inventor · Indianapolis, IN, US

Hal E. Broxmeyer

16Patents
10h-index
22Co-inventors
72Inventor score

Filing activity: Nov 12, 1987 → Jun 15, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US5192553A Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use Chemistry; Metallurgy 239 Expired
US5004681A Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Emerging Cross-Sectional Technologies 230 Expired
US6461645B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Chemistry; Metallurgy 74 Expired
US6355476B1 Nucleic acid encoding MIP-1&agr; Lymphokine Chemistry; Metallurgy 34 Expired
US6569427B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Chemistry; Metallurgy 33 Expired
US6987102B2 Methods to mobilize progenitor/stem cells Human Necessities 32 Expired
US6605275B1 Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Chemistry; Metallurgy 30 Expired
US5149544A Method of inhibiting progenitor cell proliferation Emerging Cross-Sectional Technologies 24 Expired
US7935692B2 Methods to mobilize progenitor/stem cells Human Necessities 23 Active
US7897590B2 Methods to mobilize progenitor/stem cells Human Necessities 21 Active
US5728377A Methods and compositions incorporating IP-10 Human Necessities 10 Expired
US5294544A Biologically active factor Emerging Cross-Sectional Technologies 3 Expired
US6281200A Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2 Emerging Cross-Sectional Technologies 1 Expired
US6143289A Compositions of myeloid-cell-suppressive chemokines Chemistry; Metallurgy 1 Expired
US6165459A Methods for suppressing myeloid cells with chemokines Chemistry; Metallurgy 1 Expired
US11883435B2 Compositions and methods for treating a clinical condition through the use of hematopoietic stem cells Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.